Sermorelin
Growth-hormone signaling research
Low growth-hormone production is the problem behind Sermorelin's clinical research. It stimulates the pituitary gland to release growth hormone, and studies have examined growth in children with a diagnosed deficiency. That evidence does not establish anti-aging, energy or fitness benefits from this research vial.
$129 USD
Indicative price, not an active offer. Quantity per vial is not yet confirmed.
Not accepting orders
This is a proposed research listing. Supplier terms, material specifications and lot documents must be established before commercial launch.
Product documentation
Lot-specific COA, final specification and safety documentation are not yet published.
Check Sermorelin document statusFor laboratory research only. Not for human or veterinary use.
What is being studied?
Sermorelin is associated with the GHRH(1-29) peptide fragment. Research on this region includes structure-activity experiments comparing peptide variants and their biological activity. This literature is useful for understanding why sequence changes and terminal chemistry matter when comparing research materials.
Research background: Geref study (1996): growth in children with growth-hormone deficiency; Structure-activity study (1998): human GHRH(1-29)-NH2 and analogs.
What the evidence does not establish
Findings for a defined fragment or a modified analog cannot be transferred automatically to every GHRH-related product. A research paper is not a substitute for the identity, content or quality documentation for the actual lot being considered.
Define the material first.
Confirm the precise peptide sequence, terminal chemistry, salt or other chemical form and quantity per vial. Record whether any reported quantity refers to peptide content or the total material supplied.
Before comparing price, make sure the quantities and specifications being compared are equivalent. A publication describes its study material; a supplier report describes a particular tested sample. Those are different kinds of evidence.
Read the documentation checklistQuestions about Sermorelin
Is Sermorelin the same as CJC-1295?
They are separate catalog entries. Do not treat their structures, modifications or research findings as interchangeable.
Can a shared research category establish equivalence?
No. Somatotropic is an organizational category on this website. Exact specifications and source-specific evidence remain necessary.
Sources and scope
- Geref study (1996): growth in children with growth-hormone deficiency
- Structure-activity study (1998): human GHRH(1-29)-NH2 and analogs
Source records checked September 11, 2026. This is an introductory research summary, not a systematic review, medical recommendation or lot certificate. The selection is not exhaustive. Independent scientific review and final supplier documentation remain pending.
Compare the research area